Roche
ROG.SW
276,92 €
Share price
0.35%
Change (1 day)
6.59%
Change (1 year)
Categories
Market capitalization of Roche (ROG.SW)
Market cap: €222.07 Billion
As of June 2025 Roche has a market cap of €222.07 Billion. This makes Roche the world's 44th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Roche from 2006 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | €222.07 B | 2.43% |
| 2024 | €216.79 B | 2.4% |
| 2023 | €211.72 B | -12.5% |
| 2022 | €241.96 B | -23.8% |
| 2021 | €317.56 B | 30.54% |
| 2020 | €243.26 B | -1.39% |
| 2019 | €246.69 B | 33.98% |
| 2018 | €184.12 B | 2.82% |
| 2017 | €179.07 B | -3.77% |
| 2016 | €186.09 B | -14.66% |
| 2015 | €218.04 B | 14.48% |
| 2014 | €190.47 B | 10.45% |
| 2013 | €172.44 B | -27.69% |
| 2012 | €238.48 B | 110.24% |
| 2011 | €113.43 B | 18.39% |
| 2010 | €95.81 B | -7.78% |
| 2009 | €103.89 B | 7.32% |
| 2008 | €96.80 B | -6.7% |
| 2007 | €103.76 B | -11.4% |
| 2006 | €117.11 B |
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | €315.37 B | 42.01% | 🇺🇸 USA |
 Merck MRK | €173.13 B | -22.04% | 🇺🇸 USA |
 Pfizer PFE | €118.06 B | -46.84% | 🇺🇸 USA |
 Sanofi SNY | €103.76 B | -53.27% | 🇫🇷 France |
 Novartis NVS | €199.66 B | -10.09% | 🇨🇭 Switzerland |
 GlaxoSmithKline GSK | €70.70 B | -68.16% | 🇬🇧 UK |
 Abbott Laboratories ABT | €200.33 B | -9.79% | 🇺🇸 USA |
 Amgen AMGN | €135.42 B | -39.02% | 🇺🇸 USA |
 Becton Dickinson BDX | €42.01 B | -81.08% | 🇺🇸 USA |